로딩 중…
지수 로딩 중…
Nuvalent, Inc.
NUVL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$123.43+0.06%
2026-06-18
Price Chart
Nuvalent, Inc.+63.42%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $9.75B |
| Revenue | $0.00 |
| Net Income | $-450M |
| Total Assets | $1.33B |
| Net Assets | $1.17B |
| Value | |
| P/B | 8.30x |
| FCF Yield | -3.21% |
| Profitability | |
| ROE | -38.32% |
| ROA | -33.81% |
| Financial Health | |
| Debt Ratio | 13.35% |
| Total Debt | $0.00 |
| FCF | $-313M |
| Cash | $160M |
| Current Ratio | 16.14x |
| Performance | |
| 1Y Return | 63.42% |
| 1M Return | 22.21% |
| From 52W High | -0.15% |
| 1Y MDD | -20.98% |
| Trading | |
| Volume | 3,937,528 shares |
| Trading Value | $486M |
| Per Share | |
| EPS | $-5.66 |
| BPS | $16.62 |